Salesforce
CRM
Apple
AAPL
Microsoft
MSFT
Coinbase
COIN
Meta Platforms
META
US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 16.810
- -0.640-3.67%
Close Dec 12 16:00 ET
- 16.950
- +0.140+0.83%
Pre 08:17 ET
19.05BMarket Cap-19.78P/E (TTM)
17.720High16.790Low9.83MVolume17.500Open17.450Pre Close167.18MTurnover0.87%Turnover RatioLossP/E (Static)1.13BShares19.31052wk High3.14P/B18.93BFloat Cap10.00052wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM5.33%Amplitude3.107Historical Low17.000Avg Price1Lot Size
About Teva Pharmaceutical Industries Company
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Company Profile
SymbolTEVA
Company NameTeva Pharmaceutical Industries
Listing DateMay 30, 2012
Founded1901
CEOMr. Richard D. Francis
MarketNYSE
Employees37851
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address124 Dvora HaNevi'a Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6944020
Phone972-3-914-8213
Websitehttp://www.tevapharm.com
Company Executives
- Name
- Position
- Salary
- Richard D. Francis
- Director, President and Chief Executive Officer
- 25.71M
- Eli Kalif
- Executive Vice President and Chief Financial Officer
- 4.94M
- David R. McAvoy
- Executive Vice President and Chief Legal Officer
- --
- Amir Weiss
- Senior Vice President and Chief Accounting Officer
- --
- Eric A Hughes
- Executive Vice President, Global R&D and Chief Medical Officer
- --
- Matthew Shields
- Executive Vice President, Global Operations
- --
- Christine Fox
- Executive Vice President, U.S. Commercial
- --
- Angus Grant
- Executive Vice President, Business Development
- --
- Richard Daniell
- Executive Vice President, European Commercial
- 5.16M
- Mark Sabag
- Executive Vice President, International Markets Commercial
- 3.73M
- Dr. Sol J. Barer,PhD
- Chairman of the Board
- 539.99K
- Chen Lichtenstein
- Independent Director
- --
- Rosemary A. Crane, M.B.A.
- Independent Director
- 330.00K
- Professor Ronit Satchi-Fainaro
- Independent Director
- 315.25K
- Dr. Tal Zaks, M.D.,PhD
- Independent Director
- 330.00K
- Janet S. Vergis
- Independent Director
- 325.46K
- Gerald M. Lieberman
- Independent Director
- 355.00K
- Professor Varda Shalev
- Independent Director
- 176.66K
- Amir Elstein
- Independent Director
- 340.00K
- Roberto A. Mignone
- Independent Director
- 340.00K
- Dr. Perry D. Nisen
- Independent Director
- 327.87K
- Vikki L. Conway
- Acting Head of Global Human Resources
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
